A Study of Enzalutamide, Enzalutamide in Combination With Mifepristone, or Chemotherapy in People With Metastatic Breast Cancer
Status: RECRUITING
Study type: INTERVENTIONAL
Conditions: Metastatic Breast Cancer
Interventions: DRUG: Enzalutamide|DRUG: Mifepristone|DRUG: TPC
Sponsor: Memorial Sloan Kettering Cancer Center
Collaborators: Astellas Pharma US, Inc.|Breast Cancer Research Foundation|Corcept Therapeutics